Gilead Sciences is paying $10 million for sole ownership of arenavirus immunotherapies for hepatitis B (HBV) and HIV ...

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...

Kick streamer Wes "Wesbtw" has become the centre of controversy after faking a diagnosis of Human Immunodeficiency Virus (HIV) contraction during a broadcast on Kick.

Analysts have set 12-month price targets for Vir Biotechnology, revealing an average target of $34.83, a high estimate of ...

Antimicrobial drug developer HOOKIPA Pharma (NASDAQ:HOOK) announced Thursday that Gilead Sciences (NASDAQ:GILD) has agreed to ...

Discover why Dynavax Technologies' stock dropped 25% despite HEPLISAV-B's growth & double-digit projections through 2030.

When most people think about liver disease, they usually imagine issues caused by drinking too much alcohol or infections like hepatitis B or C.

An oral presentation at ASCO & EHA Congress from the CARTITUDE-1 study highlighting heavily pre-treated patients that remain alive and progression-free for more than 5 years after a single CARVYKTI® ...

BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...

I read an article a few years back that said if you had vertigo, you more than likely would also have restless legs syndrome ...

One-time Amtagvi Treatment Demonstrated Durable Responses and a Five-year Overall Survival Rate of 20%. Five-year Follow Up is Unprecedented for Any Therapy in Patients with Advan ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...